Business Wire

Finsbury Glover Hering and Sard Verbinnen & Co to Merge, Creating Global Strategic Communications Leader

Share

Finsbury Glover Hering and Sard Verbinnen & Co (“SVC”) today announced a merger to create the world’s leading strategic communications firm advising clients in navigating critical opportunities and challenges.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211012006255/en/

The new firm will help clients achieve their missions and realize their business goals, with approximately 1,000 professionals operating from 25 offices in Asia, Europe, the Middle East and the United States, including its global headquarters in New York. Pro forma combined 2020 revenue was more than $330 million.

Over the past three decades, both firms have built impressive reputations advising clients during their most significant transformational events. The new firm will be a leader in all aspects of strategic communications, including government affairs, corporate reputation, crisis management and transformation and change, as well as the leading force in financial communications worldwide, with strong experience and expertise in M&A, private equity, IPOs, SPAC transactions, shareholder activism and restructurings.

The combined firm will offer clients world-class expertise and counsel through five integrated offerings, supported by specialist teams providing Research and Insights, Digital Strategy and Design and Creative capabilities:

  • Crisis and Issues Management, delivering sophisticated strategic thinking, candid advice and agile execution that enables clients to prepare for and manage high-stakes situations, complex issues and periods of intense scrutiny while communicating with clarity, integrity and consistency;
  • Public Policy and Government Affairs, drawing upon decades of government, campaign and policy experience and strong networks in the world’s capitals to enable clients to shape the regulatory and policy debates across leading regions;
  • Financial and Transaction Communications, advising on the world’s largest, most complex mergers and acquisitions, IPOs, SPAC transactions, restructurings, spin-offs and shareholder activist situations to help clients maximize their value and move decisively ahead;
  • Corporate Reputation, developing strategies that position clients for success, build trust with stakeholders and meet shifting societal expectations while protecting, strengthening and repairing reputations, based on in-depth research, sound judgment and creative thinking; and
  • Transformation and Change, supporting businesses and organizations at their most critical moments with internal communications that engage, empower and energize employees and other stakeholders, drive cultural change and advance business objectives.

The combined firm’s professionals have deep sector knowledge within rapidly growing industries, such as Health, Food and Agriculture and Renewable Energy, as well as expertise in Diversity, Equity and Inclusion (DE&I), Environmental, Social and Governance (ESG), litigation and regulatory communications and cybersecurity.

Senior professionals from Finsbury Glover Hering and SVC will lead the new company. George Sard will join Roland Rudd and Carter Eskew as Co-Chairmen. Alexander Geiser will serve as Global CEO; Mike Feldman and Paul Verbinnen as Co-Chairs of North America; Andrew Cole as Deputy Global CEO as well as Co-CEO of North America with Joel Johnson, Paul Kranhold and Winnie Lerner; Faeth Birch as CEO of UK, Middle East and Asia; and Brigitte von Haacke as CEO of Europe. In addition, Sanjay Bhutiani will be Global CTO, Randal Bridges will be Global CIO, Ajay Junnarkar will be Global CFO and Sydney Neuhaus will be Global COO.

Equity in the new company will be owned by nearly 40 percent of the firm’s employees. WPP will remain the majority investor. Golden Gate Capital, which is a significant minority investor in SVC, will convert its equity in SVC and remain an investor in the new firm.

Finsbury Glover Hering Global Co-Chairmen Roland Rudd and Carter Eskew said: “Our clients operate in an increasingly complex world with diverse stakeholder interests. To generate growth, open markets, shape policy and attract capital, companies need to seamlessly communicate to more audiences and across more markets than ever before. This merger brings together the most accomplished communications professionals, operating within a global firm that will have the expertise and experience to deliver reputation advisory services to address critical c-suite concerns.”

SVC Co-Founders George Sard and Paul Verbinnen added: “This is a combination of two successful, growing firms with strong track records, complementary leadership positions, deep entrepreneurial spirits, cultures of collaboration and integrity and a heritage of delivering for our clients at their most high-pressure moments. Our success has been driven by our teams’ tireless commitment to supporting our clients and one another and upholding high standards of excellence in all that we do. We are particularly excited that the combination will enable us to provide additional professional development opportunities and establish a new generation of employee owners in the combined company.”

Mark Read, CEO of WPP, said: “The demand for Board-level strategic advice on a growing range of financial, reputational and social issues has never been greater. As the reputations of companies and their brands become ever more closely linked, our leadership in this area is a core part of our offer as we support our clients’ continued transformation. WPP is delighted to support the ambitions of the leadership teams of Finsbury Glover Hering and SVC in creating a powerhouse in strategic communications, with the expertise, scale and footprint to provide unparalleled service to global clients.”

Neale Attenborough, an Operating Partner at Golden Gate Capital said: “We have a strong partnership with George, Paul and the entire SVC leadership team and have enjoyed seeing their business grow rapidly over the past five years. We are very excited about this partnership, especially as it creates the pre-eminent firm in the strategic communications sector. Golden Gate Capital will remain an investor in the combined company.”

The merger is expected to be completed in Q4 2021 and the combined company will operate under a new name starting in 2022. Financial terms of the transaction were not disclosed.

Notes to Editors

SVC has for many years been the top global transaction communications advisor on M&A, IPOs and SPACs – consistently ranked as a leader in the North America and global M&A league tables. SVC is also a leader in advising companies facing shareholder activist campaigns, a leading firm in litigation and crisis communications and has advised on many high-stakes situations around the world with particular areas of strength in the U.S. and Asia. Headquartered in New York, SVC has broad capabilities across the U.S., with strong teams in offices in San Francisco, Los Angeles, Chicago, Houston, Washington D.C. and Boston, as well as in London and Hong Kong. A South Florida office will open shortly.

Finsbury Glover Hering is a global strategic communications advisory firm, headquartered in New York with over 800 multidisciplinary experts across the world’s major financial, government, business and cultural centers. Finsbury Glover Hering is a leader in crisis, corporate reputation, public affairs and capital markets and M&A advisory, as well as an acknowledged leader in boardroom communication counsel. The company was formed through the merger of leading strategic communications consultancies Finsbury, The Glover Park Group and Hering Schuppener in January 2021. Finsbury Glover Hering serves its global client base from offices in Abu Dhabi, Beijing, Berlin, Brussels, Dubai, Dublin, Düsseldorf, Frankfurt, Hong Kong, London, Los Angeles, Munich, New York, Paris, Riyadh, Shanghai, Singapore, Tokyo, Washington D.C. and Zurich.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Press
Dorothy Burwell
Finsbury Glover Hering
dorothy@fgh.com
+44 7733 294 930

Anna Cordasco / Brooke Gordon
Sard Verbinnen & Co
cordasco@sardverb.com / bgordon@sardverb.com
212-687-8080

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Bentley Education Program Expands to Global Scope25.10.2021 23:01:00 EEST | Press release

Bentley Systems, Incorporated (Nasdaq: BSY), the infrastructure engineering software company, as a commitment to expand access to its professional applications to education, today announced the global expansion of the Bentley Education program – offering seamless access to learning licenses of over 60 popular Bentley applications, at no cost, to all eligible students and educators, from middle schools through higher education levels, via the Bentley Education portal. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211025005717/en/ The Bentley Education program helps students develop digital skills that are critical for a qualified talent pipeline to support infrastructure growth and resilience worldwide. (Photo: Business Wire) Following on the initial May 3, 2021 announcement of the launch of Bentley Education in the pilot countries of Australia, the UK, Singapore, Lithuania, and Ireland, the program is gaining a resounding r

X-Chem Acquires ComInnex25.10.2021 21:00:00 EEST | Press release

X-Chem, the pioneer of DNA-encoded library (DEL) technology and recognized leader in generating actionable results to drive small molecule drug discovery, today announced the acquisition of ComInnex, a leading European provider of synthetic chemistry services and novel chemical technologies to support early-stage drug discovery. With demand for high-quality discovery services increasing across the world, this complementary pairing of a North American leader in DEL and medicinal chemistry with a European leader in synthetic chemistry and custom DEL services delivers the capacity, footprint and expertise to better serve the demands of customers in a global market. “As a united company, with an increased global presence, we are positioned to meet the increasing demand for innovative chemistry solutions and high-quality discovery services worldwide,” noted Matt Clark, Ph.D., CEO of X-Chem. “The acquisition of ComInnex further extends X-Chem’s expertise and scale of DEL services to help bio

European Commission Selects Humanigen’s Lenzilumab as One of the 10 Most Promising Treatments for COVID-1925.10.2021 17:30:00 EEST | Press release

Humanigen, Inc. (Nasdaq: HGEN), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ with its lead drug candidate, lenzilumab, today announced the European Commission identified lenzilumab as one of the “10 most promising treatments for COVID-19” in a report and press release issued on October 22, 2021.1,2 “We are gratified the European Commission has recognized the potential of lenzilumab to offer an important treatment option for patients hospitalized with COVID-19,” said Cameron Durrant, MD, Chairman and CEO, Humanigen. “We look forward to continuing our discussions with colleagues at the European Medicines Agency to advance our efforts to submit a marketing authorization application for lenzilumab in COVID-19. We are also progressing with our early access program, under compassionate use, where allowed by regulations in some European countries and the United States.” *Lenzilumab is not authorized, or approved

Ferring Presents Award-Winning, Real-World Outcomes Analysis for Investigational Microbiota-Based Live Biotherapeutic, RBX2660, at ACG 202125.10.2021 15:00:00 EEST | Press release

Ferring Pharmaceuticals and Rebiotix, a Ferring Company, today announced the results of two key retrospective analyses at the American College of Gastroenterology 2021 annual congress. One analysis evaluated the safety and efficacy of investigational RBX2660 among a broad cohort of CDI patients with comorbidities commonly found in patients with CDI, and was recognized with a Presidential Poster Award for high-quality, novel, unique and interesting research. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211025005099/en/ Ferring Fact Sheet While the eligibility criteria in prospective clinical trials often are narrowly defined to include patients diagnosed with only CDI, this analysis allowed researchers to evaluate the impact of RBX2660 in a patient population that is more reflective of a real-world setting. In the analysis, 94 participants with comorbid conditions commonly found in people with recurrent CDI (rCDI) were trea

Study Finds Overwhelming Evidence That Color Blindness Hinders Learning in School, Reports EnChroma25.10.2021 15:00:00 EEST | Press release

EnChroma – creators of glasses for color blindness – today released the results of a landmark study that clearly demonstrates the negative effect color blindness has on learning for millions of students. The data strongly indicates that schools are failing to identify color blind students and that parents, educators and legislators need to better support these students. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211025005173/en/ Standard Color Vision and Color Blind View @EnChroma In early 2020, nearly 1,000 color blind people, including the parents of color blind children, shared their opinions about how Color Vision Deficiency (CVD) affected their educational experiences. Seventy-eight percent said they were often frustrated or confused by colors in school assignments and activities. One in three say color blindness affected their confidence in school, and 30% felt like they might be a “slow learner” before discovering

Rockefeller Capital Management to Open First International Office in London with the Formation of Rockefeller Asset Management International25.10.2021 15:00:00 EEST | Press release

Rockefeller Asset Management (RAM), a division of Rockefeller Capital Management, with a long track record of investing in global equities and ESG investing has announced the formation of Rockefeller Asset Management International, to expand its European market presence. The initial plans for expansion include opening an office in London, to better serve clients across the UK, Europe, and Asia. “Our Asset Management business has generated real momentum across Europe and we are excited to continue to serve our international clients with a full suite of sustainable investment products and a growing local presence,” said Greg Fleming, CEO and President of Rockefeller Capital Management. RAM, which was recently awarded the 2021 Principles for Responsible Investing (PRI) award for “ESG incorporation initiative of the year,” has seen strong growth in Europe. Over the last two years, the business, which surpassed $2.5 billion in assets from European investors, launched a UCITS ICAV, an Irelan

CAPRISA and Evotec Launch New Project to Fast-Track New Technology for HIV Prevention25.10.2021 14:53:00 EEST | Press release

Today, at a side meeting during the AU-EU Ministerial Summit in Kigali, Rwanda, Prof Salim Abdool Karim, Director of CAPRISA, announced a collaboration with a leading life science company Evotec for the designing and development of CAP256, a broadly neutralizing antibody against HIV. The project is a major expansion of the development of an antibody originally developed jointly by CAPRISA and the Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases of the US NIH. This new project is a major boost for the CAP256 antibody as a potential tool in the fight against HIV in Africa and showcases the potential of African researchers to fight the continent’s high-burden diseases. The principal aim of the new joint project is to change the course of the HIV epidemic in Africa, which has 70% of the global HIV burden. CAP256, isolated from a South African woman by CAPRISA and the VRC, has demonstrated a good safety profile in Phase I studies. The next step is t

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom